Effects of GHB On Psychomotor and Driving Performance
- PMID: 29366411
- DOI: 10.2174/1389200219666180124113802
Effects of GHB On Psychomotor and Driving Performance
Abstract
Background: Gamma-hydroxybutyrate (γ-hydroxybutyrate or GHB) is a physiological compound of mammalians with specific receptors in central nervous system (CNS). Apart from an endogenous production, GHB is also an exogenous molecule found in pharmaceutical as well as in illicit formulations. Products manufactured and spread in these two fields, whose borders are all but strictly defined and traced, differ for the in vivo effects and for the potential of abuse. Illicit GHB gained public attention due to its use as a sexual assault facilitator. Notwithstanding its popularity, the effects on human performances, are still not completely understood and could be more complex than expected. Therefore, there is a real public safety concern regarding psychomotor functions and driving abilities due to GHB ingestion.
Objective: To provide an updated and complete review on the effects of GHB on psychomotor, cognitive and driving performance that may be useful for judiciary expert forensic evaluation of driving under the influence of GHB (GHB-DUI).
Method: Experimental animal-based and human-based studies and case series or epidemiological studies regarding driving under influence of GHB (and its precursors) were reviewed using main scientific databases.
Results: The effects of GHB on cognitive, psychomotor and driving performance are dose-related in experimental studies. In real cases of driving under the influence of GHB, severe impairment is observed. In these cases, a wide range of blood GHB levels are found. Possible long-term effects are also reported.
Conclusion: GHB causes cognitive and psychomotor impairment and risky driving behavior. Multiple aspects and variables are still waiting clarification, such as the harmful potential of illicit preparations, the effect of precursors and impairing dosages. GHB (and its precursors) must be considered a substantial personal and public risk even in the absence of a clear dose-effects correlation.
Keywords: GHB; cognitive performance; driving safety; driving skills; psychomotor performance; γ-hydroxybutyrate..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.Psychopharmacology (Berl). 2018 Nov;235(11):3223-3232. doi: 10.1007/s00213-018-5025-2. Epub 2018 Sep 19. Psychopharmacology (Berl). 2018. PMID: 30232528 Free PMC article. Clinical Trial.
-
Driving under the influence of GHB?J Anal Toxicol. 1994 Oct;18(6):357-8. doi: 10.1093/jat/18.6.357. J Anal Toxicol. 1994. PMID: 7823545
-
Driving under the influence of non-alcohol drugs--An update. Part II: Experimental studies.Forensic Sci Rev. 2016 Jul;28(2):79-101. Forensic Sci Rev. 2016. PMID: 27257716 Review.
-
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.Brain Res Bull. 2016 Sep;126(Pt 1):47-60. doi: 10.1016/j.brainresbull.2016.02.002. Epub 2016 Feb 11. Brain Res Bull. 2016. PMID: 26855327 Review.
-
Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers.Psychopharmacology (Berl). 2009 Sep;206(1):141-54. doi: 10.1007/s00213-009-1589-1. Epub 2009 Jun 20. Psychopharmacology (Berl). 2009. PMID: 19543883 Free PMC article.
Cited by
-
Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.Psychopharmacology (Berl). 2018 Nov;235(11):3223-3232. doi: 10.1007/s00213-018-5025-2. Epub 2018 Sep 19. Psychopharmacology (Berl). 2018. PMID: 30232528 Free PMC article. Clinical Trial.
-
Effects of synthetic cannabinoids on psychomotor, sensory and cognitive functions relevant for safe driving.Front Psychiatry. 2022 Sep 26;13:998828. doi: 10.3389/fpsyt.2022.998828. eCollection 2022. Front Psychiatry. 2022. PMID: 36226105 Free PMC article.
-
Comparison of N-methyl-2-pyrrolidone (NMP) and the "date rape" drug GHB: behavioral toxicology in the mouse model.Psychopharmacology (Berl). 2021 Aug;238(8):2275-2295. doi: 10.1007/s00213-021-05852-5. Epub 2021 Apr 21. Psychopharmacology (Berl). 2021. PMID: 33881584
-
Sensorimotor Alterations Induced by Novel Fentanyl Analogs in Mice: Possible Impact on Human Driving Performances.Curr Neuropharmacol. 2023;21(1):87-104. doi: 10.2174/1570159X21666221116160032. Curr Neuropharmacol. 2023. PMID: 36397617 Free PMC article.
-
Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy.Ther Clin Risk Manag. 2020 Nov 12;16:1099-1108. doi: 10.2147/TCRM.S244714. eCollection 2020. Ther Clin Risk Manag. 2020. PMID: 33209031 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical